tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of James Condulis, 19 are a BUY (90.48%), 2 are a HOLD (9.52%).
Analyst James Condulis, currently employed at STIFEL, carries an average stock price target met ratio of 48.33% that have a potential upside of 46.01% achieved within 134 days.
James Condulis’s has documented 42 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MIRM, Mirum Pharmaceuticals at 29-Apr-2026.
Analyst best performing recommendations are on EWTX (EDGEWISE THERAPEUTICS).
The best stock recommendation documented was for SLNO (SOLENO THERAPEUTICS) at 3/12/2025. The price target of $74 was fulfilled within 43 days with a profit of $27.3 (58.46%) receiving and performance score of 13.59.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Mar-2014
$140
$66.23 (89.78%)
$140
17 days ago
(31-Aug-2026)
45/76 (59.21%)
$69.09 (97.43%)
809
Buy Since 09-Dec-2022
$103
$29.23 (39.62%)
$97
1 months 4 days ago
(13-Aug-2026)
9/11 (81.82%)
$29.55 (40.23%)
330
Buy Since 20-Dec-2022
$112
$38.23 (51.82%)
$92
1 months 7 days ago
(10-Aug-2026)
6/8 (75%)
$34.51 (44.53%)
366
Buy Since 08-Nov-2024
$112
$38.23 (51.82%)
$117
1 months 10 days ago
(07-Aug-2026)
4/10 (40%)
$35.24 (45.91%)
448
Buy Since 04-Feb-2022
$112
$38.23 (51.82%)
$102
1 months 10 days ago
(07-Aug-2026)
26/32 (81.25%)
$35.24 (45.91%)
328
Which stock is James Condulis most bullish on?
What Year was the first public recommendation made by James Condulis?
